Article
Conjunctival melanoma : a multicentre study correlating baseline clinical features with histology and genetics
2017-01-01
Abstract excerpt
Conjunctival melanoma (CoM) is a rare, but potentially fatal, malignancy constituting about 2% of all ocular cancers. Despite successful local primary CoM treatment, an estimated 60% recur locally within 5 years, and are fatal in 26% at 10 years. Because of CoM rarity, management of patients varies between centres, and the protocols are based on limited case series and reports rather than randomised clinical trial...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 13a2a776-4e45-5337-b491-0e1d603b1ecc
- DOI
- 10.17638/03009316
